Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 March
Sonoma Pharmaceuticals, Inc. has filed 974 SEC EDGAR filings since 15 Jan 2002

SEC filing history

Showing 376-400 of 746 matching filings.

Per page
25
Current page
16
NT 10-Q File 001-33216

EXTENSION

Filing date
14 Feb 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
09 Feb 2017
Reporting date
09 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

CURRENT REPORT ON FORM 8-K

Filing date
23 Jan 2017
Reporting date
17 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Jan 2017
Reporting date
19 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
10 Jan 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33216

CT ORDER filing

Filing date
05 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Dec 2016
Reporting date
08 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 Dec 2016
Reporting date
08 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
07 Dec 2016
Reporting date
06 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Dec 2016
Reporting date
30 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Dec 2016
Reporting date
30 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Dec 2016
Reporting date
30 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
01 Dec 2016
Reporting date
30 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Nov 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Nov 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Nov 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Nov 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-214760

FORM S-8

Filing date
22 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-195554

PROSPECTUS SUPPLEMENT

Filing date
18 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-33216

EXTENSION

Filing date
15 Nov 2016
Reporting date
30 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
10 Nov 2016
Reporting date
10 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

CURRENT REPORT

Filing date
31 Oct 2016
Reporting date
27 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-33216

FORM 8-A 12(B)

Filing date
21 Oct 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
21 Oct 2016
Reporting date
18 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .